Association between Dyslipidemia and Peritoneal Dialysis Technique Survival.
Atherogenic dyslipidemia
PD adequacy
Peritoneal dialysis
Technique failure
Technique survival
Journal
Open access Macedonian journal of medical sciences
ISSN: 1857-9655
Titre abrégé: Open Access Maced J Med Sci
Pays: North Macedonia
ID NLM: 101662294
Informations de publication
Date de publication:
15 Aug 2019
15 Aug 2019
Historique:
received:
21
03
2019
revised:
02
06
2019
accepted:
03
06
2019
entrez:
1
11
2019
pubmed:
2
11
2019
medline:
2
11
2019
Statut:
epublish
Résumé
A large body of research has investigated the effects of pro-atherogenic lipid profile on cardiovascular diseases (CVD) in peritoneal dialysis (PD) patients. However, there is a general lack of research on the association between atherogenic dyslipidemia and PD technique survival. The study aimed to define the association between dyslipidemia and PD technique survival. It was a prospective single-centre observational study involving 40 outpatients on continuous ambulatory PD treatment for more than 3 months between 2010 and 2016 in a single centre in Ukraine. There were 27 males and 13 females. The mean age of the participants was 49.3 ± 12.2 years. The primary outcome measures were all-cause technique failure. Atherogenic dyslipidemia was identified in 28/40 (70 %) patients and correlated with PD adequacy parameters. During the 36-month- follow-up period technique failure occurred in 2/12 (16.6 %) patients with atherogenic dyslipidemia compared with 12 / 28 (42.9 %) patients without atherogenic dyslipidemia (χ The presence of atherogenic dyslipidemia was significantly associated with a higher risk of technique failure in PD patients. This is an important issue for future research. Further well-designed clinical trials are needed to determine the impact of dyslipidemia on PD adequacy and technique survival.
Sections du résumé
BACKGROUND
BACKGROUND
A large body of research has investigated the effects of pro-atherogenic lipid profile on cardiovascular diseases (CVD) in peritoneal dialysis (PD) patients. However, there is a general lack of research on the association between atherogenic dyslipidemia and PD technique survival.
AIM
OBJECTIVE
The study aimed to define the association between dyslipidemia and PD technique survival.
METHODS
METHODS
It was a prospective single-centre observational study involving 40 outpatients on continuous ambulatory PD treatment for more than 3 months between 2010 and 2016 in a single centre in Ukraine. There were 27 males and 13 females. The mean age of the participants was 49.3 ± 12.2 years. The primary outcome measures were all-cause technique failure.
RESULTS
RESULTS
Atherogenic dyslipidemia was identified in 28/40 (70 %) patients and correlated with PD adequacy parameters. During the 36-month- follow-up period technique failure occurred in 2/12 (16.6 %) patients with atherogenic dyslipidemia compared with 12 / 28 (42.9 %) patients without atherogenic dyslipidemia (χ
CONCLUSION
CONCLUSIONS
The presence of atherogenic dyslipidemia was significantly associated with a higher risk of technique failure in PD patients. This is an important issue for future research. Further well-designed clinical trials are needed to determine the impact of dyslipidemia on PD adequacy and technique survival.
Identifiants
pubmed: 31666849
doi: 10.3889/oamjms.2019.664
pii: OAMJMS-7-2467
pmc: PMC6814482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2467-2473Informations de copyright
Copyright: © 2019 Natalia Stepanova, Olena Burdeyna.
Références
Clin Chim Acta. 2014 Mar 20;430:109-14
pubmed: 24333488
Inflammation. 2013 Jun;36(3):689-95
pubmed: 23321723
Mediators Inflamm. 2012;2012:912595
pubmed: 22547910
Nutrients. 2018 Mar 03;10(3):null
pubmed: 29510483
Cardiorenal Med. 2013 Oct;3(3):165-177
pubmed: 24454313
Contrib Nephrol. 2009;163:140-146
pubmed: 19494607
Int J Nephrol. 2014;2014:909373
pubmed: 24895536
Perit Dial Int. 2006 Sep-Oct;26(5):523-39
pubmed: 16973506
Clinics (Sao Paulo). 2015 Sep;70(9):601-5
pubmed: 26375560
J Am Soc Nephrol. 2003 Nov;14(11):2851-60
pubmed: 14569095
Clin Kidney J. 2014 Jun;7(3):330-5
pubmed: 25852905
J Am Soc Nephrol. 2012 Mar;23(3):533-44
pubmed: 22302194
Indian J Nephrol. 2010 Apr;20(2):59-67
pubmed: 20835317
Open Cardiovasc Med J. 2011;5:41-8
pubmed: 21643500
J Am Soc Nephrol. 2016 Nov;27(11):3238-3252
pubmed: 27339663
Int J Nephrol Renovasc Dis. 2017 Feb 07;10:35-45
pubmed: 28223836
J Diabetes Sci Technol. 2009 Nov 01;3(6):1472-80
pubmed: 20144403
JAMA. 2004 Jan 28;291(4):451-9
pubmed: 14747502
Clin Kidney J. 2016 Jun;9(3):374-80
pubmed: 27274820
Nephrol Dial Transplant. 2006 Oct;21(10):2881-92
pubmed: 16735386
PLoS One. 2014 Oct 06;9(10):e109558
pubmed: 25286027
Medicine (Baltimore). 2015 Mar;94(10):e619
pubmed: 25761189
Perit Dial Int. 2015 Dec;35(7):691-702
pubmed: 26152580
Ann Intern Med. 2005 Aug 2;143(3):174-83
pubmed: 16061915
Nephrol Dial Transplant. 1997;12 Suppl 1:68-73
pubmed: 9075233
Int J Nephrol. 2014;2014:693670
pubmed: 25505992
Perit Dial Int. 2016 Mar-Apr;36(2):146-53
pubmed: 26429421
Kidney Dis (Basel). 2017 Jan;2(4):187-196
pubmed: 28232935
Nephrol Dial Transplant. 2011 Dec;26(12):4047-54
pubmed: 21565947
Perit Dial Int. 1998 Mar-Apr;18(2):166-71
pubmed: 9576364
PLoS One. 2016 Dec 16;11(12):e0167258
pubmed: 27992532